897 related articles for article (PubMed ID: 25524899)
1. Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.
Makkouk A; Weiner GJ
Cancer Res; 2015 Jan; 75(1):5-10. PubMed ID: 25524899
[TBL] [Abstract][Full Text] [Related]
2. Multiple-purpose immunotherapy for cancer.
Seledtsov VI; Goncharov AG; Seledtsova GV
Biomed Pharmacother; 2015 Dec; 76():24-9. PubMed ID: 26653546
[TBL] [Abstract][Full Text] [Related]
3. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
Mapara MY; Sykes M
J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
[TBL] [Abstract][Full Text] [Related]
4. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
5. Future approaches in immunotherapy.
Rini B
Semin Oncol; 2014 Oct; 41 Suppl 5():S30-40. PubMed ID: 25438998
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy: new insights].
Geissler M; Weth R
Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
Mocellin S; Rossi CR; Nitti D
Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
[TBL] [Abstract][Full Text] [Related]
8. [Cancer immunotherapy. Importance of overcoming immune suppression].
Malvicini M; Puchulo G; Matar P; Mazzolini G
Medicina (B Aires); 2010; 70(6):565-70. PubMed ID: 21163748
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
10. Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use?
Strioga MM; Darinskas A; Pasukoniene V; Mlynska A; Ostapenko V; Schijns V
Vaccine; 2014 Jul; 32(32):4015-24. PubMed ID: 24837511
[TBL] [Abstract][Full Text] [Related]
11. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?
Ferris RL
ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):332-40. PubMed ID: 15668533
[TBL] [Abstract][Full Text] [Related]
12. T cell tolerance to tumors and cancer immunotherapy.
Shafer-Weaver K; Anderson M; Malyguine A; Hurwitz AA
Adv Exp Med Biol; 2007; 601():357-68. PubMed ID: 17713024
[TBL] [Abstract][Full Text] [Related]
13. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
Lynch DH
Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
[TBL] [Abstract][Full Text] [Related]
14. Role of Local Radiation Therapy in Cancer Immunotherapy.
Demaria S; Golden EB; Formenti SC
JAMA Oncol; 2015 Dec; 1(9):1325-32. PubMed ID: 26270858
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic cancer/testis antigens: prime candidates for immunotherapy.
Gjerstorff MF; Andersen MH; Ditzel HJ
Oncotarget; 2015 Jun; 6(18):15772-87. PubMed ID: 26158218
[TBL] [Abstract][Full Text] [Related]
16. Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment.
Bastien JP; Minguy A; Dave V; Roy DC
Semin Immunol; 2019 Apr; 42():101306. PubMed ID: 31604534
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
18. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Schijns V; Tartour E; Michalek J; Stathopoulos A; DobrovolskienÄ— NT; Strioga MM
Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
[TBL] [Abstract][Full Text] [Related]
19. Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.
Chatterjee M; Draghici S; Tainsky MA
Curr Opin Drug Discov Devel; 2006 May; 9(3):380-5. PubMed ID: 16729735
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of immunotherapy.
Disis ML
Semin Oncol; 2014 Oct; 41 Suppl 5():S3-13. PubMed ID: 25438997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
